Hot Features
Premium
Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.
Period:
Draw Mode:
Low
0.15
High
0.26
| Share Name | Share Symbol | Market | Stock Type |
|---|---|---|---|
| Helix BioPharma Corp | HBP | Toronto | Common Stock |
| Price Change | Price Change % | Share Price | Last Trade
|
|
|---|---|---|---|---|
| 0.00 | 0.00% | 0.21 | 14:47:58 |
| Open Price | Low Price | High Price | Close Price | Previous Close |
|---|---|---|---|---|
| 0.21 | 0.21 | 0.21 | 0.21 | 0.21 |
| Trades | Shares Traded | Average Volume | 52 Week Range |
|---|---|---|---|
| 7 | 15,300 | - | 0.15 - 0.26 |
| Last Trade | Type | Quantity | Price | Currency |
|---|---|---|---|---|
| 14:47:58 | 500 | $ 0.21 | CAD |
Helix BioPharma Corp Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| 42M | 200.02M | - | 0 | -6.29M | -0.03 | - |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | - | - | - |
Helix BioPharma News
| Date | Time | Source | News Article |
|---|---|---|---|
| 4/01/2024 | 08:13 | PR Newswire (Canada) | L'Organisme canadien de réglementation des investissements.. |
| 4/01/2024 | 08:11 | PR Newswire (Canada) | Canadian Investment Regulatory Organization Trade Resumption.. |
| 3/28/2024 | 16:22 | PR Newswire (Canada) | Suspension de la négociation par l'Organisme canadien de.. |
| 3/28/2024 | 16:14 | PR Newswire (Canada) | Canadian Investment Regulatory Organization Trading Halt -.. |
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical HBP Price Data
| Period † | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 0.19 | 0.21 | 0.175 | 0.1987794 | 10,593 | 0.02 | 10.53% |
| 1 Month | 0.18 | 0.21 | 0.16 | 0.18781 | 8,250 | 0.03 | 16.67% |
| 3 Months | 0.195 | 0.25 | 0.16 | 0.1816143 | 13,739 | 0.015 | 7.69% |
| 6 Months | 0.19 | 0.255 | 0.16 | 0.2098884 | 19,106 | 0.02 | 10.53% |
| 1 Year | 0.205 | 0.26 | 0.15 | 0.2137055 | 13,086 | 0.005 | 2.44% |
| 3 Years | 0.85 | 0.97 | 0.15 | 0.3219268 | 16,063 | -0.64 | -75.29% |
| 5 Years | 0.53 | 2.01 | 0.15 | 0.4750856 | 20,558 | -0.32 | -60.38% |
Helix BioPharma Description
| Helix BioPharma Corp is a clinical-stage biopharmaceutical company. It is focused on cancer drug development. |
